| Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells N Gagliani, CF Magnani, S Huber, ME Gianolini, M Pala, P Licona-Limon, ... Nature medicine 19 (6), 739-746, 2013 | 918 | 2013 |
| Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation N Gagliani, MCA Vesely, A Iseppon, L Brockmann, H Xu, NW Palm, ... Nature 523 (7559), 221-225, 2015 | 857 | 2015 |
| IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine S Huber, N Gagliani, LA Zenewicz, FJ Huber, L Bosurgi, B Hu, M Hedl, ... Nature 491 (7423), 259-263, 2012 | 816 | 2012 |
| Control of TH17 cells occurs in the small intestine E Esplugues, S Huber, N Gagliani, AE Hauser, T Town, YY Wan, ... Nature 475 (7357), 514-518, 2011 | 714 | 2011 |
| Th17 cells express interleukin-10 receptor and are controlled by Foxp3− and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner S Huber, N Gagliani, E Esplugues, W O'Connor, FJ Huber, A Chaudhry, ... Immunity 34 (4), 554-565, 2011 | 698 | 2011 |
| Epithelial IL-18 equilibrium controls barrier function in colitis R Nowarski, R Jackson, N Gagliani, MR de Zoete, NW Palm, W Bailis, ... Cell 163 (6), 1444-1456, 2015 | 558 | 2015 |
| Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells L Bosurgi, YG Cao, M Cabeza-Cabrerizo, A Tucci, LD Hughes, Y Kong, ... Science 356 (6342), 1072-1076, 2017 | 519 | 2017 |
| The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases MG Roncarolo, S Gregori, R Bacchetta, M Battaglia, N Gagliani Immunity 49 (6), 1004-1019, 2018 | 298 | 2018 |
| Th9 cells drive host immunity against gastrointestinal worm infection P Licona-Limón, J Henao-Mejia, AU Temann, N Gagliani, I Licona-Limón, ... Immunity 39 (4), 744-757, 2013 | 247 | 2013 |
| Memory/effector (CD45RBlo) CD4 T cells are controlled directly by IL-10 and cause IL-22–dependent intestinal pathology M Kamanaka, S Huber, LA Zenewicz, N Gagliani, C Rathinam, ... Journal of Experimental Medicine 208 (5), 1027-1040, 2011 | 229 | 2011 |
| Human fetal TNF-α-cytokine-producing CD4+ effector memory T cells promote intestinal development and mediate inflammation early in life RRCE Schreurs, ME Baumdick, AF Sagebiel, M Kaufmann, M Mokry, ... Immunity 50 (2), 462-476. e8, 2019 | 202 | 2019 |
| Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney CF Krebs, HJ Paust, S Krohn, T Koyro, SR Brix, JH Riedel, P Bartsch, ... Immunity 45 (5), 1078-1092, 2016 | 197 | 2016 |
| T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response EAC Silva, PY Chan, L Joannas, AE Errasti, N Gagliani, L Bosurgi, ... Immunity 39 (1), 160-170, 2013 | 188 | 2013 |
| Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer J Tintelnot, Y Xu, TR Lesker, M Schönlein, L Konczalla, AD Giannou, ... Nature 615 (7950), 168-174, 2023 | 180 | 2023 |
| Regulation of TH17 Cells and Associated Cytokines in Wound Healing, Tissue Regeneration, and Carcinogenesis L Brockmann, AD Giannou, N Gagliani, S Huber International journal of molecular sciences 18 (5), 1033, 2017 | 159 | 2017 |
| MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient mice N Hoshi, D Schenten, SA Nish, Z Walther, N Gagliani, RA Flavell, B Reizis, ... Nature communications 3 (1), 1120, 2012 | 159 | 2012 |
| Clonal expansion and activation of tissue-resident memory-like TH17 cells expressing GM-CSF in the lungs of patients with severe COVID-19 Y Zhao, C Kilian, JE Turner, L Bosurgi, K Roedl, P Bartsch, AC Gnirck, ... Science Immunology 6 (56), eabf6692, 2021 | 158 | 2021 |
| Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer L Bosurgi, JH Bernink, V Delgado Cuevas, N Gagliani, L Joannas, ... Proceedings of the National Academy of Sciences 110 (32), 13091-13096, 2013 | 156 | 2013 |
| Skin-resident innate lymphoid cells converge on a pathogenic effector state P Bielecki, SJ Riesenfeld, JC Hütter, E Torlai Triglia, MS Kowalczyk, ... Nature 592 (7852), 128-132, 2021 | 149 | 2021 |
| The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer. J Geginat, P Larghi, M Paroni, G Nizzoli, A Penatti, M Pagani, N Gagliani, ... Cytokine & growth factor reviews 30, 87-93, 2016 | 149 | 2016 |
